- cafead Sep 21, 2023 at 11:52: AM
via In a patent case centered on two rival hemophilia medicines, Roche's Genentech unit has scored its second straight win.
After a U.S. district court last year ruled in favor of Roche and invalidated a patent held by Takeda's Baxalta unit, the U.S. Court of Appeals for the Federal Circuit reaffirmed the ruling.
article source
After a U.S. district court last year ruled in favor of Roche and invalidated a patent held by Takeda's Baxalta unit, the U.S. Court of Appeals for the Federal Circuit reaffirmed the ruling.
article source